Skip to main content

US Market Update

Stocks closed lower, Tuesday, finishing near their lows for the session and snapping a four-day winning streak as Congress continues to wrangle over terms to extend the nation's borrowing authority and end the partial government shutdown. House Republicans were reportedly planning a vote late Tuesday evening, although it was far from certain the measure had sufficient support to win passage. Senate leadership also has been working on compromise legislation, although that measure apparently has been on hold until a House deal emerges. 

Earnings Distraction
A fresh slate of financial results helped provide a much-needed distraction to the fiscal discord in Washington. Citigroup (C) ended lower Tuesday after posting earnings and revenue lagging both year-ago comparisons and analyst projections. Johnson & Johnson (JNJ) close slightly higher after beating consensus opinion with its latest EPS and sales. The healthcare conglomerate also increased its FY13 guidance. 

Economic data included the Empire State Manufacturing Survey, which fell to a 1.52 reading in October, down from a 6.29 score during the prior month and trailing Wall Street expectations for a small rise to 7.0. Also, Tuesday, sales for larger retailers as measured by the International Council of Shopping Centers and Goldman Sachs fell a larger-than-expected 0.7% from last week although year-over-year sales were up 1%. 

Commodities were mostly lower. Crude oil for November delivery settled $1.20 lower at $101.21 per barrel while November natural gas is fell 3 cents to $3.79 per 1 million BTU. December gold fell $3.30 to finish at $1,273.30 per ounce while December silver slid 16 cents to $21.19 per ounce. December copper rose a penny, settling at $3.31 per pound.

Here's Where The Markets Stood At Day's End
  • Dow Jones Industrial Average down 133.25 (-0.87%) to 15,168.01
  • S&P 500 down 12.08 (-0.71%) to 1,698.06
  • Nasdaq Composite Index down 21.26 (-0.56%) to 3,794.01
GLOBAL SENTIMENT
  • Hang Seng Index up 0.51%
  • Shanghai China Composite Index down 0.19%
  • FTSE 100 Index up 0.64%
UPSIDE MOVERS
  • (+) TSLA, Wedbush upgrade to Outperform from Neutral; price target raised by 33% to $240 a share.
  • (+) TUC, Agrees to $524-million buyout by CSC Serviceworks.
  • (+) NVGN, Seeking Alpha article labels the pharmaceutical company "the most exciting idea in biotech."
DOWNSIDE MOVERS
  • (-) SVNT, Drug-maker files for Chapter 11 bankruptcy protection.
  • (-) CWTR, Warns Q3 earnings will miss expectations and says the company is exploring strategic alternatives.
  • (-) TDC, Issues disappointing earnings forecasts, prompting a rash of analyst downgrades from Credit Suisse, Goldman Sachs and William Blair.

Comments

Popular posts from this blog

Wizard of Dalal Street: Govind Parikh's investment mantra

Wizard of Dalal Street: Govind Parikh's investment mantra Govind Parikh of Govind Parikh Securities says selling right is more important than correct buying. He says it is necessary to keep a lot of cash. "We keep an average 10 percent cash in our portfolio," he says I like to buy things in a bad market. Additionally, don't look current cash flow, concentrate on future cash flows — that is what  I look at," says Govind Parikh of Govind Parikh Securities. He advises investors to buy good quality stocks when the market crashes. While sharing his investment philosophy with ace investor Ramesh Damani, on the Wizards of Dalal Street, Parikh says management integrity is very important when deciding which stock to bet on. He tells investors not to buy stocks impulsively. According to him, selling right is more important than correct buying. He says it is necessary to keep a lot of cash. "We keep an average 10 percent cash in our portfolio," he says. He al...

Bank Nifty

Bank Nifty Bank Nifty is a Sell at Current Levels with a Stop Loss of 12,750 Once Below 12,400 the next major Support shall be only 12,000 Levels so a person can go short is bearish or buy putt if moderately bearish . 

Budget 2018: Mega health plan to cost Rs 1 lakh crore

The mega healthcare plan for the poor, as announced in the Budget, will cost about Rs 1,00,000 crore annually and curtail states' autonomy to design their own policies in the sector, says a research paper, authored by a professor at economic think tank NIPFP. The paper's estimate is 10 times higher than the one made last week by Niti Aayog adviser Alok Kumar, who had said that the National Health Protection Scheme (NHPS) will cost around Rs 10,000-12,000 crore annually. National Institute of Public Finance and Policy (NIPFP) Assistant Professor Mita Choudhury said in the paper -- 'The National Health Protection Scheme in the Union  Budget 2018 : Is it in the Right Direction?' -- that resource requirements for implementing NHPS are likely to be very high. Not only would such a scheme impose a heavy burden on both the Union and the states' exchequers, it will also curtail states' autonomy to design their own policies in a sector that is constitutionally ma...